The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Yong Beom KimJu-Hyun KimDong Hoon SuhKidong KimJae Hong NoYong Beom KimPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
A cervical tumor larger than 2.7 cm before radical surgery in stage IB2 may predispose to potential complications from combining radical hysterectomy and concurrent chemoradiation,. We consider that concurrent chemoradiation therapy is a more appropriate choice for tumor size over 2.7 cm per the revised FIGO 2018 criteria for stage IB2 cervical cancer.